These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 10193720)
21. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Raviele A; Giada F; Menozzi C; Speca G; Orazi S; Gasparini G; Sutton R; Brignole M; Eur Heart J; 2004 Oct; 25(19):1741-8. PubMed ID: 15451153 [TBL] [Abstract][Full Text] [Related]
22. Midodrine: a role in the management of neurocardiogenic syncope. Ward CR; Gray JC; Gilroy JJ; Kenny RA Heart; 1998 Jan; 79(1):45-9. PubMed ID: 9505918 [TBL] [Abstract][Full Text] [Related]
23. Response to treatment during medium-term follow-up in a series of patients with neurocardiogenic syncope. Lafuente EA; Martínez LC; Moguel JO; David RN; García JD; Tejeda AO; Reyes PH; González VR Arch Med Res; 2004; 35(5):416-20. PubMed ID: 15610912 [TBL] [Abstract][Full Text] [Related]
24. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Raviele A; Brignole M; Sutton R; Alboni P; Giani P; Menozzi C; Moya A Circulation; 1999 Mar; 99(11):1452-7. PubMed ID: 10086969 [TBL] [Abstract][Full Text] [Related]
26. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. Madrid AH; Ortega J; Rebollo JG; Manzano JG; Segovia JG; Sánchez A; Peña G; Moro C J Am Coll Cardiol; 2001 Feb; 37(2):554-9. PubMed ID: 11216978 [TBL] [Abstract][Full Text] [Related]
27. Central serotonergic responsiveness in neurocardiogenic syncope: a clomipramine test challenge. Theodorakis GN; Markianos M; Livanis EG; Zarvalis E; Flevari P; Kremastinos DT Circulation; 1998 Dec; 98(24):2724-30. PubMed ID: 9851959 [TBL] [Abstract][Full Text] [Related]
28. A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the Prevention of Syncope Trial VI. Sheldon RS; Lei L; Guzman JC; Kus T; Ayala-Paredes FA; Angihan J; Safdar S; Maxey C; Bennett G; Raj SR Europace; 2019 Nov; 21(11):1733-1741. PubMed ID: 31538180 [TBL] [Abstract][Full Text] [Related]
29. Head-up tilt test with clomipramine challenge in vasovagal syndrome--a new tilt testing protocol. Theodorakis GN; Livanis EG; Leftheriotis D; Flevari P; Markianos M; Kremastinos DT Eur Heart J; 2003 Apr; 24(7):658-63. PubMed ID: 12657224 [TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope]. Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barsotti A Cardiologia; 1998 Aug; 43(8):833-7. PubMed ID: 9808874 [TBL] [Abstract][Full Text] [Related]
32. A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Ventura R; Maas R; Zeidler D; Schoder V; Nienaber CA; Schuchert A; Meinertz T Pacing Clin Electrophysiol; 2002 May; 25(5):816-21. PubMed ID: 12049374 [TBL] [Abstract][Full Text] [Related]
33. Effects of closed-loop stimulation vs. DDD pacing on haemodynamic variations and occurrence of syncope induced by head-up tilt test in older patients with refractory cardioinhibitory vasovagal syncope: the Tilt test-Induced REsponse in Closed-loop Stimulation multicentre, prospective, single blind, randomized study. Palmisano P; Dell'Era G; Russo V; Zaccaria M; Mangia R; Bortnik M; De Vecchi F; Giubertoni A; Patti F; Magnani A; Nigro G; Rago A; Occhetta E; Accogli M Europace; 2018 May; 20(5):859-866. PubMed ID: 28407148 [TBL] [Abstract][Full Text] [Related]
34. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope. Grubb BP; Kosinski D; Mouhaffel A; Pothoulakis A Pacing Clin Electrophysiol; 1996 May; 19(5):836-40. PubMed ID: 8734752 [TBL] [Abstract][Full Text] [Related]
35. Midodrine hydrochloride in the treatment of vasovagal syncope. Mitro P; Trejbal D; Rybár AR Pacing Clin Electrophysiol; 1999 Nov; 22(11):1620-4. PubMed ID: 10598965 [TBL] [Abstract][Full Text] [Related]
36. Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Takata TS; Wasmund SL; Smith ML; Li JM; Joglar JA; Banks K; Kowal RC; Page RL; Hamdan MH Circulation; 2002 Sep; 106(12):1500-4. PubMed ID: 12234955 [TBL] [Abstract][Full Text] [Related]
37. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. Moya A; Permanyer-Miralda G; Sagrista-Sauleda J; Carne X; Rius T; Mont L; Soler-Soler J J Am Coll Cardiol; 1995 Jan; 25(1):65-9. PubMed ID: 7798528 [TBL] [Abstract][Full Text] [Related]
38. Pathophysiology and management of neurocardiogenic syncope. Nair N; Padder FA; Kantharia BK Am J Manag Care; 2003 Apr; 9(4):327-34; quiz 335-6. PubMed ID: 12703677 [TBL] [Abstract][Full Text] [Related]
39. Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope. Grubb BP; Karas B; Kosinski D; Boehm K J Interv Card Electrophysiol; 1999 Jul; 3(2):139-43. PubMed ID: 10387140 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis. Lei LY; Raj SR; Sheldon RS Heart Rhythm; 2020 Jul; 17(7):1151-1158. PubMed ID: 32151742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]